Objective: To develop a closed, automated system that standardizes the processing of human adipose tissue to obtain and concentrate regenerative cells suitable for clinical treatment of thermal and radioactive burn wounds. Approach: A medical device was designed to automate processing of adipose tissue to obtain a clinical-grade cell output of stromal vascular cells that may be used immediately as a therapy for a number of conditions, including nonhealing wounds resulting from radiation damage. Results: The Celution® System reliably and reproducibly generated adipose-derived regenerative cells (ADRCs) from tissue collected manually and from three commercial power-assisted liposuction devices. The entire process of introducing tissue into the system, tissue washing and proteolytic digestion, isolation and concentration of the nonadipocyte nucleated cell fraction, and return to the patient as a wound therapeutic, can be achieved in approximately 1.5 h. An alternative approach that applies ultrasound energy in place of enzymatic digestion demonstrates extremely poor efficiency cell extraction. Innovation: The Celution System is the first medical device validated and approved by multiple international regulatory authorities to generate autologous stromal vascular cells from adipose tissue that can be used in a real-time bedside manner. Conclusion: Initial preclinical and clinical studies using ADRCs obtained using the automated tissue processing Celution device described herein validate a safe and effective manner to obtain a promising novel cell-based treatment for wound healing.
Objective: To develop a closed, automated system that standardizes the processing of human adipose tissue to obtain and concentrate regenerative cells suitable for clinical treatment of thermal and radioactive burn wounds. Approach: A medical device was designed to automate processing of adipose tissue to obtain a clinical-grade cell output of stromal vascular cells that may be used immediately as a therapy for a number of conditions, including nonhealing wounds resulting from radiation damage. Results: The Celution® System reliably and reproducibly generated adipose-derived regenerative cells (ADRCs) from tissue collected manually and from three commercial power-assisted liposuction devices. The entire process of introducing tissue into the system, tissue washing and proteolytic digestion, isolation and concentration of the nonadipocyte nucleated cell fraction, and return to the patient as a wound therapeutic, can be achieved in approximately 1.5 h. An alternative approach that applies ultrasound energy in place of enzymatic digestion demonstrates extremely poor efficiency cell extraction. Innovation: The Celution System is the first medical device validated and approved by multiple international regulatory authorities to generate autologous stromal vascular cells from adipose tissue that can be used in a real-time bedside manner. Conclusion: Initial preclinical and clinical studies using ADRCs obtained using the automated tissue processing Celution device described herein validate a safe and effective manner to obtain a promising novel cell-based treatment for wound healing.
Authors: Jaco H Houtgraaf; Wijnand K den Dekker; Bas M van Dalen; Tirza Springeling; Renate de Jong; Robert J van Geuns; Marcel L Geleijnse; Francisco Fernandez-Aviles; Felix Zijlsta; Patrick W Serruys; Henricus J Duckers Journal: J Am Coll Cardiol Date: 2012-01-31 Impact factor: 24.094
Authors: K Lin; Y Matsubara; Y Masuda; K Togashi; T Ohno; T Tamura; Y Toyoshima; K Sugimachi; M Toyoda; H Marc; A Douglas Journal: Cytotherapy Date: 2008 Impact factor: 5.414
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: P Gottlöber; M Steinert; M Weiss; V Bebeshko; D Belyi; N Nadejina; F H Stefani; G Wagemaker; T M Fliedner; R U Peter Journal: Radiat Res Date: 2001-03 Impact factor: 2.841
Authors: Katja Schenke-Layland; Brian M Strem; Maria C Jordan; Michael T Deemedio; Marc H Hedrick; Kenneth P Roos; John K Fraser; W Robb Maclellan Journal: J Surg Res Date: 2008-04-10 Impact factor: 2.192
Authors: Simen W Schive; Mohammad Reza Mirlashari; Grete Hasvold; Mengyu Wang; Dag Josefsen; Hans Petter Gullestad; Olle Korsgren; Aksel Foss; Gunnar Kvalheim; Hanne Scholz Journal: Cell Med Date: 2017-04-14
Authors: Philippe Foubert; Andreina D Gonzalez; Stephan Teodosescu; Felipe Berard; Melanie Doyle-Eisele; Krishna Yekkala; Mayer Tenenhaus; John K Fraser Journal: Adv Wound Care (New Rochelle) Date: 2016-07-01 Impact factor: 4.730
Authors: Simon Zimmermann; Richard M Fakin; Thomas Giesen; Pietro Giovanoli; Maurizio Calcagni Journal: J Vis Exp Date: 2017-11-23 Impact factor: 1.355